Gene · 8720
Papers2,858
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,858
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Macrophage extracellular traps amplify retinal endothelial anoikis via the S1P-S1PR axis in diabetic retinopathy. | J Transl Med | 2026 | 41639891 | PubTator, text mining | PubMed |
| [XVII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2024 ECTRIMS Congress (I)]. | Rev Neurol | 2026 | 41609134 | PubTator, text mining | PubMed |
| Metabolic reprogramming of efferocytosis in the tumour microenvironment: From apoptotic-cell clearance to therapeutic targeting. | Clin Transl Med | 2026 | 41601343 | PubTator, text mining | PubMed |
| Building the blood-brain barrier: a scalable self-assembling 3D model of the brain microvasculature under unidirectional flow. | Fluids Barriers CNS | 2026 | 41578393 | PubTator, text mining | PubMed |
| Targeting SPHK1 by 8-HETrE attenuates MASH-Driven fibrosis via restoration of hepatic stellate cell mitochondrial dynamics. | Cell Biol Toxicol | 2026 | 41546802 | PubTator, text mining | PubMed |
| Association of treatment decision with personality, coping strategies and impulsivity in patients with multiple sclerosis. | Mult Scler J Exp Transl Clin | 2026 | 41541187 | PubTator, text mining | PubMed |
| The expanding role of Nogo-B in hypertension: linking kidney physiology, endothelial function and inflammation. | J Hypertens | 2026 | 41537371 | PubTator, text mining | PubMed |
| When clearance fails: the role of efferocytosis in COPD. | Eur Respir Rev | 2026 | 41534890 | PubTator, text mining | PubMed |
| Multicellular, Biochemical, and Perfusion Effects on Vessel Network Morphogenesis in a Microfluidic Vasculature-on-a-Chip. | ACS Biomater Sci Eng | 2026 | 41490845 | PubTator, text mining | PubMed |
| Organelle-specific regulation of ferroptosis. | Biol Direct | 2026 | 41484993 | PubTator, text mining | PubMed |
| Smart integrated biomaterial systems for precision and optimized delivery of MSCs and their exosomes: Transforming wound healing and organ regeneration. | Regen Ther | 2026 | 41399764 | PubTator, text mining | PubMed |
| Plantaginis Semen, a Novel Natural S1PR1 Agonist, Inhibits Oxidative Stress and Inflammation to Treat Lipopolysaccharide-Induced Acute Lung Injury. | Phytother Res | 2026 | 41321047 | PubTator, text mining | PubMed |
| Nedd4 family interacting protein 1 (NDFIP1) is a novel target of PF-429242 in promoting autophagy in hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2026 | 41317707 | PubTator, text mining | PubMed |
| Liquiritigenin attenuates alcohol-induced liver inflammation by regulating the SphK1/S1P/SPNS2 signaling pathway. | Int Immunopharmacol | 2026 | 41297343 | PubTator, text mining | PubMed |
| Novel oxadiazole analogs as anticancer agents: Design, synthesis, in vitro and in vivo biological evaluation, and computer studies of sphingosine kinase inhibitors. | Bioorg Med Chem | 2026 | 41273810 | PubTator, text mining | PubMed |
| Novel MBTPS1 Variants and Cutis Laxa Phenotype in the 8th Reported Case of Spondyloepiphyseal Dysplasia, Kondo-Fu Type. | Clin Genet | 2026 | 41024587 | PubTator, text mining | PubMed |
| Infection toxicity assessment of tumor necrosis factor α inhibitors in the treatment of IBD: a real-world study based on the US food and drug administration adverse events reporting system (FAERS). | Expert Opin Drug Saf | 2026 | 40156444 | PubTator, text mining | PubMed |
| The gut microbiota composition is shaped by disease activity and individual treatment responses in patients with multiple sclerosis. | Front Immunol | 2025 | 41766816 | PubTator, text mining | PubMed |
| Unveiling the role of the respiratory microbiome in long COVID pathogenesis and therapeutics. | Chin Med J Pulm Crit Care Med | 2025 | 41551009 | PubTator, text mining | PubMed |
| Study on the CHJ01 antitumor activity and mechanism via targeting sphingosine kinase 1 in A549 cells. | Pharm Sci Adv | 2025 | 41550642 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8720/papers?page=6